REG - MicroSalt PLC Tekcapital plc - Notice of Presentation on Investor Meet Company

TekcapitalAnnouncement

01/02/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240201:nRSA6006Ba&default-theme=true

RNS Number : 6006B  MicroSalt PLC  01 February 2024

1 February 2024

MicroSalt plc

("MicroSalt" or the "Company")

 

Notice of Presentation on Investor Meet Company

 

MicroSalt plc, (AIM: SALT) a company commercialising a patented technology to
produce full-flavour, low-sodium salt for food manufacturers and consumers, is
pleased to announce that following its admission to trading on AIM this
morning, Rick Guiney (CEO) and Konrad Dabrowski (CFO) will hold a live
presentation on the Company via the Investor Meet Company platform on 5
February 2024 at 4pm (UK local time).

 

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to
meet MicroSalt plc via:

https://www.investormeetcompany.com/microsalt-plc/register
(https://www.investormeetcompany.com/microsalt-plc/register)

 

Investors who already follow MicroSalt plc on the Investor Meet Company
platform will automatically be invited.

 For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) , follow on twitter @microSaltPLC or contact:

 

 MicroSalt plc                                                 Via Flagstaff PR
 Rick Guiney, CEO

 Zeus (Nominated Adviser and Broker)                           +44 (0)20 3829 5000
 David Foreman / James Edis (Investment Banking)
 Dom King (Corporate Broking), Rupert Woolfenden (Sales)

 Flagstaff PR (Financial PR)                                   +44 (0)20 7129 1474
 Tim Thompson / Alison Allfrey / Anna Probert

 microsalt@flagstaffcomms.com

 

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its
micron sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the average
salt intake was reduced by one gram per day, it has been estimated that 4,147
lives and £288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70 per cent. of the
typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt uses a patent-protected technology which
helps create high barriers to entry within the reduced-sodium salt market. The
group has a US patent and 14 patent applications pending in other
jurisdictions globally.

 

The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.

 

MicroSalt has a three-pronged marketing strategy, targeting large B2B food
manufacturers, the B2C market and e-commerce customers. Microsalt's all
natural, low-sodium solution is well positioned to take advantage of the
fast-growing market for a healthier alternative to traditional salt.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBBMRTMTIJBAI